Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'

被引：1
|
作者：
Wang, Weijie [1 ]
Lee, Yung-Heng [2 ,3 ,4 ]
Wei, James Cheng Chung [5 ,6 ,7 ]
机构：
[1] Zhejiang Chinese Med Univ, Dept Rheumatol, Affiliated Hosp 2, Hangzhou, Peoples R China
[2] Minghsin Univ Sci & Technol, Dept Sr Serv Ind management, Hsinchu, Taiwan
[3] Shu Te Univ, Dept Recat & Sport Management, Kaohsiung, Taiwan
[4] Cishan Hosp, Dept Orthoped, Minist Hlth & Welf, Kaohsiung, Taiwan
[5] Chung Shan Med Univ, Inst Med, Taichung 404, Taiwan
[6] Chung Shan Med Univ Hosp, Dept Allergy Immunol & Rheumatol Taiwan, Taichung, Taiwan
[7] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年
基金：
中国国家自然科学基金;
关键词：
spondylitis; ankylosing; epidemiology; arthritis;
D O I：
10.1136/annrheumdis-2021-220938
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 45 条
  • [21] Adalimumab is effective in patients with preradiographic axial spondyloarthritis (PRSPA): Results of a 12-week, randomised controlled trial with a 40-week open-label extension (OLE)
    Haibel, H.
    Rudwaleit, M.
    Amtenbrink, A.
    Heldmann, F.
    Listing, J.
    Wong, R.
    Kupper, H.
    Braun, J.
    Sieper, J.
    RHEUMATOLOGY, 2008, 47 : II80 - II80
  • [22] Effectiveness of methotrexate with step-down glucocorticoid remission induction ( COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
    Verschueren, Patrick
    De Cock, Diederik
    Corluy, Luk
    Joos, Rik
    Langenaken, Christine
    Taelman, Veerle
    Raeman, Frank
    Ravelingien, Isabelle
    Vandevyvere, Klaas
    Lenaerts, Jan
    Geens, Elke
    Geusens, Piet
    Vanhoof, Johan
    Durnez, Anne
    Remans, Jan
    Vander Cruyssen, Bert
    Van Essche, Els
    Sileghem, An
    De Brabanter, Griet
    Joly, Johan
    Meyfroidt, Sabrina
    Van der Elst, Kristien
    Westhovens, Rene
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (03) : 511 - 520
  • [23] Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
    Ahmed, Rukhsana
    Poespoprodjo, Jeanne R.
    Syafruddin, Din
    Khairallah, Carole
    Pace, Cheryl
    Lukito, Theda
    Maratina, Sylvia S.
    Asih, Puji B. S.
    Santana-Morales, Maria A.
    Adams, Emily R.
    Unwin, Vera T.
    Williams, Christopher T.
    Chen, Tao
    Smedley, James
    Wang, Duolao
    Faragher, Brian
    Price, Richard N.
    ter Kuile, Feiko O.
    LANCET INFECTIOUS DISEASES, 2019, 19 (09): : 973 - 987
  • [24] The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea: a pragmatic, cluster-randomised, stepped-wedge, open-label trial
    Mohamed, Yasmin
    Htay, Hla
    Gare, Janet
    Vallely, Andrew J. B.
    Kelly-Hanku, Angela
    Yee, Win Lei
    Agius, Paul A.
    Badman, Steven G.
    Duc, Minh
    Nightingale, Claire
    Chen, Xiang-Sheng
    Kombati, Zure
    Koata, Amelia
    Munnull, Gloria
    Silim, Selina
    Thein, Win
    Zaw, Tin Maung
    Kyaw, Latt Latt
    Stoove, Mark
    Crowe, Suzanne M.
    Anderson, David
    Tin, Htay Htay
    Luchters, Stanley
    LANCET HIV, 2023, 10 (04): : E220 - E229
  • [25] THE ONE-YEAR RADIOGRAPHIC PROGRESSION AND MINIMAL DISEASE ACTIVITY IN EARLY PSORIATIC ARTHRITIS PATIENTS TREATED ACCORDING TO TREAT-TO-TARGET STRATEGY (RESULTS OF AN ONGOING OPEN-LABEL REMARCA STUDY)
    Loginova, E.
    Korotaeva, T.
    Smirnov, A.
    Koltakova, A.
    Karateev, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 943 - 944
  • [26] Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial
    Smit, Mikaela
    Marinosci, Annalisa
    Nicoletti, Giovanni Jacopo
    Perneger, Thomas
    Ragozzino, Silvio
    Andrey, Diego O.
    Stoeckle, Marcel
    Jacquerioz, Frederique
    Lebowitz, Dan
    Agoritsas, Thomas
    Meyer, Benjamin
    Spechbach, Herve
    Salamun, Julien
    Back, Moritz
    Schaubhut, Carla
    Fuchs, Simon
    Decosterd, Laurent
    Battegay, Manuel
    Guessous, Idris
    Chappuis, Francois
    Kaiser, Laurent
    Labhardt, Niklaus D.
    Calmy, Alexandra
    BMJ OPEN, 2020, 10 (11):
  • [27] Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
    Lean, Michael E. J.
    Leslie, Wilma S.
    Barnes, Alison C.
    Brosnahan, Naomi
    Thom, George
    McCombie, Louise
    Peters, Carl
    Zhyzhneuskaya, Sviatlana
    Al-Mrabeh, Ahmad
    Hollingsworth, Kieren G.
    Rodrigues, Angela M.
    Rehackova, Lucia
    Adamson, Ashley J.
    Sniehotta, Falko F.
    Mathers, John C.
    Ross, Hazel M.
    McIlvenna, Yvonne
    Welsh, Paul
    Kean, Sharon
    Ford, Ian
    McConnachie, Alex
    Messow, Claudia-Martina
    Sattar, Naveed
    Taylor, Roy
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (05): : 344 - 355
  • [28] DURATION OF REMISSION AND MINIMAL DISEASE ACTIVITYAFTER STARTING AND DISCONTINUATION OF BIOLOGIC (B) DMARDS IN EARLY PSORIATIC ARTHRITIS PATIENTS TREATED ACCORDING TO TREAT-TO-TARGET STRATEGY (RESULTS OF AN OPEN-LABEL REMARCA STUDY)
    Loginova, E.
    Korotaeva, T.
    Gubar, E.
    Glukhova, S.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1028 - 1028
  • [29] Treat-to-Target Approaches in Early Psoriatic Arthritis: Early Secukinumab versus Standard Care-12-and 24-Week Results from a Multicenter, Open-Label, Randomized Controlled Trial
    Koc, Gonul Hazal
    Kok, Marc R.
    Kasiem, Fazira R.
    Luime, Jolanda
    Tchetverikov, Ilja
    Wilhelm-de Jong, Kim
    Korswagen, Lindy A.
    Bijsterbosch, Jessica
    Goekoop-Ruiterman, Yvonne P. M.
    Baudoin, Paul
    Kok, Petra
    Bos, Reinhard
    Dolhain, Radboud J. E. M.
    Vis, Marijn
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2956 - 2959
  • [30] Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
    Gough, Stephen C. L.
    Bode, Bruce
    Woo, Vincent
    Rodbard, Helena W.
    Linjawi, Sultan
    Poulsen, Pernille
    Damgaard, Lars H.
    Buse, John B.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (11): : 885 - 893
12345